Captopril
(Capoten)
Category:
Description:
Indications:
-
Hypertension,
heart failure, left ventricular dysfunction after MI
-
Diabetic
nephropathy in Type 1 patients (proteinuria > 500mg/daily)
Contraindications:
Precautions:
-
Pregnancy
category C (1st trimester) and D (3rd trimester)
-
Dialysis
patients, hypovolemia, leukemia, scleroderma, lupus erythematosus
-
Blood
dyscrasias, thyroid disease, COPD, asthma, CHF, hyperkalemia
-
Potassium
sparing diruretics, cough, aortic stenosis, pediatric use
Adverse
Reactions (Side Effects):
-
CNS:
chills, fever
-
CV:
chest pain, hypotension, palpitations, postural hypotension,
tachycardia
-
GI:
loss of taste
-
GU:
acute reversible renal failure, dysuria, frequency, impotence,
nephrotic syndrome, oliguria, polyuria, proteinuria
-
HEME:
agranulocytosis, neutropenia
-
METAB:
hyperkalemia, hyponatremia
-
RESP:
angioedema, bronchospasm, cough, dyspnea
-
SKIN:
rash
|
Dosage:
Administered
orally
-
Adult:
-
Hypertensive
crisis: PO 25mg, increasing every 2 hours until desired
response; do not exceed 450mg daily
-
Hypertension: PO initial dose 12.5mg 2-3 times daily; may increase to 50mg 2-3
times daily at 1-2 week intervals; usual range 25-150mg 2-3 times
daily; max 450mg daily
-
Diabetic
nephropathy: PO 25mg 3 times daily
-
Congestive
heart failure: PO 12.5mg 2-3 times daily; may increase to 50mg
2-3 times daily; after 14 days, may increase to 150mg 3 times
daily if needed
-
Child:
Drug
Interactions:
-
Allopurinol:
increased risk of hypersensitivity reactions including Stevens-Johnson
syndrome, skin eruptions, fever, and arthralgias
-
NSAIDS:
inhibits the antihypertensive response to ACE inhibition
-
Lithium:
increased risk of lithium toxicity
|
Home
· Military Medicine
· Sick Call · Basic Exams
· Medical Procedures
· Lab and X-ray · The Pharmacy
· The Library · Equipment
· Patient Transport
· Medical Force
Protection · Operational Safety · Operational
Settings · Special
Operations · Humanitarian
Missions · Instructions/Orders · Other Agencies · Video Gallery
· Forms · Web Links · Acknowledgements
· Help · Feedback Approved for public release;
Distribution is unlimited. The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.
Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.
Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300 |
Operational Medicine
Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
January 1, 2001 |
United States Special Operations
Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323 |
*This web version is provided by The Brookside Associates, LLC. It contains
original contents from the official US Navy NAVMED P-5139, but has been
reformatted for web access and includes advertising and links that were not
present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the
Department of the Navy or the Department of Defense. The presence of any
advertising on these pages does not constitute an endorsement of that product or
service by either the US Department of Defense or the Brookside Associates. The
Brookside Associates is a private organization, not affiliated with the United
States Department of Defense.
© 2015, Brookside Associates, LLC. All rights reserved
Other Brookside Products
|
|